Duration: (2:11) ?Subscribe5835 2025-02-07T14:13:52+00:00
Acasti Pharma Inc. (Nasdaq: ACST): Virtual Investor Conferences
(28:53)
Acasti Pharma (ACST) is innovating in the treatment for hemorrhagic stroke.
(21:37)
NEXT BIG BREAKOUT : ACST STOCK ANALYSIS | ACASTI PHARMA INC STOCK
(2:9)
đź”´ Acasti Pharma Inc. ACST Stock Trading Facts đź”´
(30)
Acasti Pharma | Developing Innovative Drugs to Tackle Heart Disease
(3:53)
Acasti Pharma Financial Stock Review: Penny stock today but tomorrow may be different: $ACST
(9:17)
ACST STOCK ANALYSIS | ACASTI PHARMA INC TRADING UPSWING
(2:14)
Acasti Pharma's CaPre Drug Is A No Go --- $ACST
(14:13)
“The Buzz” Show: Acasti Pharma Inc. (NASDAQ: ACST) to Acquire Grace Therapeutics, Inc.
(48)
Cramer: This biotech stock could be worth over $100 billion on an FDA approval
(5:19)
Me preguntan mucho en que invertir
(9:50)
Senesco Technologies at the 2010 OneMedForum
(6:56)
All Access: Growth Stocks
(2:56:3)
Pharmapack 2025 Recap
(1:40)
Pfizer's Environmental, Social and Governance Strategy
(1:47)
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
(5:12)
BLSSS 2023 | AdjuTec Pharma
(11:50)
Phase 3 Drugs to Watch: Spring 2023 Investor Conference Panel
(42:47)
Acasti Pharma Inc. - ACST Stock Chart Technical Analysis for 07-22-2019
(4:2)
ACASTI PHARMA INC HUGE SWING IN PROJECTED GROWTH ​| ACASTI PHARMA INC | ACASTI PHARMA INC NEWS
(6:50)
Why ACST (Acasti Pharma)- $1 Penny Stock is a Buy- With %1000 Potential
(6:13)
Acasti Pharma Quick profits
(59)
Acasti Pharma Inc Stock with a potential uptrend #acst - acst stock
(2:20)
Acasti Pharma Inc Stock hits the support level #acst - acst stock
(2:11)
Acasti Pharma Inc Stock with a potential of big move #acst - acst stock
(1:35)
Acasti Pharma Inc. (TSXV: ACST) - 2019 TSX Venture 50
(42)
WATCH THIS STOCK Tomorrow! Acasti Pharma Inc ($ACST) Up 100% Today
(7:39)
Acasti Pharma Inc. (TSXV: APO) Interview - The Howard Group
(9:52)
Acasti Pharma ($ACST) // Xphere Research now bearish due to PR from Dec. 23, 2019
(9:31)
Dr. Waksal Interview Part 2 -- An Important Introduction To Acasti?
(13:17)